tiprankstipranks
Trending News
More News >
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
US Market

Appili Therapeutics Inc Class A (APLIF) Financial Statements

Compare
82 Followers

Appili Therapeutics Inc Class A Financial Overview

Appili Therapeutics Inc Class A's market cap is currently $1.41M. The company's EPS TTM is $-0.0051297190000000005; its P/E ratio is -0.81; Appili Therapeutics Inc Class A is scheduled to report earnings on February 12, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 20Jun 19
Income Statement
Total RevenueC$ 100.44KC$ 334.18KC$ 1.39MC$ 0.00C$ 199.11K
Gross ProfitC$ 100.44KC$ 327.91KC$ 1.39MC$ -14.84KC$ 199.11K
Operating IncomeC$ -190.84KC$ -7.91MC$ -24.68MC$ -16.30MC$ -6.13M
EBITDAC$ 360.57KC$ -8.10MC$ -23.51MC$ -14.87MC$ -5.63M
Net IncomeC$ -2.62MC$ -9.24MC$ -25.12MC$ -14.33MC$ -5.42M
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.23MC$ 2.47MC$ 6.66MC$ 16.12MC$ 10.54M
Total AssetsC$ 3.03MC$ 3.13MC$ 8.28MC$ 18.32MC$ 11.17M
Total DebtC$ 12.29MC$ 7.67MC$ 4.98MC$ 1.03MC$ 1.00M
Net DebtC$ 11.07MC$ 5.20MC$ -1.69MC$ -10.03MC$ -9.50M
Total LiabilitiesC$ 16.43MC$ 10.53MC$ 11.55MC$ 5.56MC$ 2.33M
Stockholders' EquityC$ -13.40MC$ -7.40MC$ -3.27MC$ 12.75MC$ 8.85M
Cash Flow
Free Cash FlowC$ 866.46KC$ -10.10MC$ -19.08MC$ -11.46MC$ -4.26M
Operating Cash FlowC$ 868.82KC$ -10.10MC$ -19.08MC$ -11.45MC$ -4.26M
Investing Cash FlowC$ -2.36KC$ -3.17KC$ 5.06MC$ -4.99MC$ -1.14K
Financing Cash FlowC$ 193.68KC$ 5.91MC$ 9.56MC$ 17.02MC$ 9.36M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

Appili Therapeutics Inc Class A Debt to Assets

Appili Therapeutics Inc Class A Cash Flow

Appili Therapeutics Inc Class A Forecast EPS vs Actual EPS